TIS 0.00% 0.0¢ tissue therapies limited

The impending announcement

  1. 347 Posts.
    Since the EMA review is all about manufacturing I think the delay in announcing the CHMP meeting outcome is due to Mercer and his team liaising with Catalent etc on what is needed, how it can be obtained and how long it will take to get the info.

    the longer this takes the more complicated the outstanding issues must be.

    Not looking good.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.